- •Ocular Blood Flow
- •Contents
- •1: Anatomy of the Ocular Vasculatures
- •Core Messages
- •1.1 Limbus and Conjunctiva
- •1.1.1 Cornea
- •1.1.2 Vasculature Distribution in the Anterior Segment
- •1.1.3 The Conjunctiva
- •1.1.3.1 The Conjunctival Arterial Supply
- •1.1.3.2 The Conjunctival Veins
- •1.2 Uveal Tract
- •1.2.1 The Iris
- •1.2.1.1 The Major Arterial Circle of the Iris
- •1.2.2 Ciliary Body and Processes
- •1.2.3 Choroid and Suprachoroid
- •1.2.3.1 Development of the Choroidal Vasculature
- •1.2.3.2 Arteries
- •1.2.3.3 Choroidal Veins (Vortex Veins)
- •1.2.3.4 Choriocapillaris
- •1.3 Optic Nerve Vasculature
- •1.4 Retina
- •1.4.1 Development of the Retinal Vasculature
- •1.4.2 Adult Retinal Vasculature
- •1.4.3 Nonprimate Adult Retinal Vasculatures
- •1.5 Conclusions
- •References
- •Core Messages
- •2.1 Introduction
- •2.3 Stochastic Error in the Entrapment of Microspheres
- •2.4 Methodological Errors and Practical Advice
- •2.4.1 Size of the Microspheres
- •2.4.2 Physical Characteristics of Microspheres
- •2.4.4 Dissection
- •2.4.5 Detection of RM and NAM
- •2.4.6 Detection of CM and FM
- •2.5 Biological Variation
- •2.5.1 Blood Pressure
- •2.5.3 Arterial Blood Gases
- •2.5.4 Other Possible Causes for Biological Variability
- •2.6 Summary for the Clinician
- •References
- •3: Laser Doppler Flowmetry in Animals
- •Core Messages
- •3.1 Introduction
- •3.2 History
- •3.3 Theory
- •3.4 Validation
- •3.5 Calibration
- •3.6 Zero Offset
- •3.7 Effects of Oxygen
- •3.9 Measurement Depth and Sampling Volume
- •3.10 Caveats
- •References
- •4: Oxygen Measurements in Animals
- •Core Messages
- •4.1 Introduction
- •4.2.1 Oxygen Electrodes
- •4.2.2 Hypoxyprobe
- •4.2.3 Magnetic Resonance Imaging
- •4.2.4 Phosphorescence Decay
- •4.2.5 Oximetry
- •4.3.1 Vitreal Oxygen
- •4.3.2 Intraretinal Oxygen
- •4.4 Oxygen in Avascular Retinas
- •4.5 Analysis of Retinal Oxygen Utilization
- •4.5.1 Fick Principle Analyses
- •4.5.4 Other Diffusion Models
- •4.6 Physiological Variations in Retinal Oxygen
- •4.6.1 Light
- •4.6.2 Hypoxia
- •4.6.3 Hyperoxia
- •4.6.4 Hypercapnia
- •4.7 Pathophysiology and Retinal Oxygen
- •4.7.1 Vascular Occlusion
- •4.7.2 Diabetes
- •4.7.3 Retinal Detachment
- •4.7.4 Retinal Degenerative Diseases
- •4.7.5 Retinopathy of Prematurity
- •4.8 Retinal Molecular Changes Related to Oxygen
- •4.9 Oxygen in the Optic Nerve Head
- •References
- •Core Messages
- •5.1 Measuring Technique
- •5.2 Normal Values
- •5.3 Retinal Pathologies
- •5.3.1 Diabetes Mellitus
- •5.3.2 Central Retinal Vein Occlusion
- •5.4 Summary
- •References
- •Core Messages
- •6.1 Introduction
- •6.1.1 Anatomy
- •6.3 Vessel Diameter Measurements Based on Photographic and Digitally Stored Images
- •6.3.1 Basics for Measurements on Stored Images
- •6.3.1.1 Measuring Principle
- •6.3.1.4 Problems and Measuring Errors
- •6.3.1.5 Physiological Variability of Vessel Diameter
- •6.3.2 Methods
- •6.3.2.2 Microdensitometry Based on Photographic Negatives
- •6.3.2.3 Measurements Based on Digital Images
- •6.4 Diameter Assessment for Blood Flow
- •6.4.1 Assessment of Flow by Use of Doppler Technique (CLBF)
- •6.5 Retinal Vessel Analysis
- •6.5.1 Basics of Retinal Vessel Analysis
- •6.5.2 Static Vessel Analysis
- •6.5.3 Results and Limits of Static Vessel Analysis
- •6.5.4 Results and Limits of Dynamic Vessel Analysis
- •6.5.4.1 Stimulation with Flicker Light
- •6.5.4.2 Other Provocation Tests
- •6.5.5 Systems Available for Dynamic Vessel Analysis
- •6.6 Further Perspectives
- •References
- •Core Messages
- •7.1 Introduction
- •7.2 Retinal Laser Doppler Velocimetry
- •7.2.1 The Doppler Effect
- •7.2.2 Electric Field Scattered by Singly Scattering Particles Moving in a Capillary Tube
- •7.2.5 Experimental Test of the Bidirectional LDV Technique
- •7.2.7 The DSPS for RBCs Moving in a Retinal Vessel
- •7.2.7.1 Multiple Scattering of Blood
- •7.2.7.2 DSPS from RBCs Flowing in a Glass Capillary Tube
- •7.2.7.3 DSPS from Human Retinal Vessels
- •7.2.7.4 Exploring the Scattering Process
- •7.2.9 Instrumentation
- •7.2.10 Blood Flow in Retinal Vessels
- •7.2.12 Limitations, Safety, and Future Directions of the LDV Technique
- •7.2.13 Physiologic and Clinical Applications (Brief Overview)
- •7.3.1 The DSPS for RBCs Moving in the Microvascular Bed of a Tissue
- •7.3.2 Hemodynamic Parameters Derived from the DSPS
- •7.3.3 Detection Scheme for Optic Nerve and Subfoveal Choroidal Blood Flow
- •7.3.4 Critical Questions Regarding the Application of LDF to Ocular Blood Flow
- •7.3.4.1 LDF Sample Volume
- •7.3.4.2 Linearity of LDF
- •7.3.4.3 Scattering Scheme
- •7.3.5 Reproducibility of LDF
- •7.3.6 Applications of LDF
- •7.4 Summary for the Clinician
- •References
- •8: Color Doppler Imaging
- •Core Messages
- •8.1 Principles
- •8.2 Instrumentation
- •8.3 Procedure
- •8.4 Outcome Variables
- •8.5 Reproducibility
- •8.6 Physiological and Pharmacological Stimuli
- •8.7 Results in Patients with Disease
- •8.8 Advantages and Limitations
- •References
- •9: Other Approaches
- •Core Messages
- •9.1 Blue Field Entoptic Technique
- •9.1.1 Laser Speckle Technique
- •9.1.2 Pulsatile Ocular Blood Flow
- •9.1.2.1 Laser Interferometry
- •References
- •10: Systemic Determinants
- •Core Messages
- •10.1 Introduction
- •10.1.1 Ocular and Systemic Blood Flow
- •10.2 Local Skin Cooling Effect
- •10.2.1 Choroidal Blood Flow
- •10.2.2 Retinal Blood Flow
- •10.3 Aerobic Exercise
- •10.3.1 Choroidal Blood Flow
- •10.3.2 Macular Blood Flow
- •10.3.3 Retinal Blood Flow
- •10.4 Neural Activation
- •10.4.1 Valsalva Maneuver
- •10.4.2 Nicotine
- •10.5 Blood Pressure Versus Ocular Perfusion Pressure
- •10.5.1 Increased Ocular Perfusion Pressure
- •10.5.1.1 Choroidal Blood Flow
- •10.5.2 Decreased Ocular Perfusion Pressure
- •10.5.2.1 Choroidal Blood Flow
- •10.5.2.2 Optic Nerve Head Blood Flow
- •10.5.3 Neural Retinal Function
- •10.6 Blood Gases
- •10.6.1 Hyperoxia and Blood Flow
- •10.6.3 Hypoxia and Pulsatile Choroidal Blood Flow
- •10.6.4 Hyperoxia, Hypercapnia, and Retinal Function
- •10.6.5 Hypoxia, Hyperoxia, and Retinal Function
- •10.7 Regional Choroidal Perfusion
- •10.7.1 Cones Versus Rods: Structure and Function
- •10.7.2 Choroidal Angioarchitecture
- •10.7.3 Dark Adaptation
- •10.7.4 Protracted Blue Flicker
- •10.8 Aging
- •10.8.1 Structure
- •10.8.2 Blood Flow
- •10.8.3 Retinal Function
- •References
- •11: Local Determinants
- •Core Messages
- •11.1 Introduction
- •11.2 Ocular Perfusion Pressure, IOP, and the Ocular Starling Resistor Effect
- •11.3 Types of Local Control
- •11.3.1 Myogenic Local Control
- •11.3.2 Metabolic Local Control
- •11.3.3 Flow-Mediated Vasodilation
- •11.3.4 Flow Control by Intercellular Conduction
- •11.4 Ocular Local Control
- •11.4.1 Optic Nerve Head (ONH)
- •11.4.2 Choroid
- •11.4.3 Retina
- •11.4.4 Ciliary Body
- •11.4.5 Iris
- •11.5 Caveats
- •11.6 Summary for the Clinician
- •References
- •12: Neural Control of Ocular Blood Flow
- •Core Messages
- •12.1 Overview of Ocular Blood Supplies and Their Neural Control
- •12.2 Neural Control of Optic Nerve and Retinal Blood Flow
- •12.3 Neural Control of Iridial and Ciliary Body Blood Flow
- •12.4 Neural Control of Blood Flow in Orbital Glands
- •12.5 Neural Control of Choroidal Blood Flow
- •12.5.1 Importance of the Choroid
- •12.5.2 Choroidal Innervation: Overview of Anatomy
- •12.5.3 Facial Nucleus Parasympathetic Input
- •12.5.3.4 Choroidal Autoregulation and the PPG Input to Choroid – Mammals
- •12.5.3.8 Choroidal Autoregulation and the PPG Input to Choroid – Birds
- •12.5.4 Oculomotor Nucleus Parasympathetic Input
- •12.5.4.1 Ciliary Ganglion Circuitry – Mammals
- •12.5.4.2 Function of the EW-Ciliary Ganglion Circuit – Mammals
- •12.5.4.3 Ciliary Ganglion Circuitry – Birds
- •12.5.4.4 Function of vSCN-EWM-Ciliary Ganglion Circuit – Birds
- •12.5.5 Sympathetic Superior Cervical Ganglion Input
- •12.5.6 Trigeminal Sensory Input
- •12.5.7 Intrinsic Choroidal Neurons
- •12.5.8 Disturbed Neural Control of Choroidal Blood Flow in Aging and Retinal Disease
- •12.5.8.1 Effect of Aging on Retina and Choroid
- •12.5.8.2 Effect of Disease on Retina and Choroid
- •References
- •13: Endothelial and Adrenergic Control
- •Core Messages
- •13.1 Nitric Oxide
- •13.2 Endothelins
- •13.3 Arachidonic Acid Metabolites
- •13.4 Adrenergic Control
- •13.5 Alpha Receptors
- •13.6 Topical Administration
- •13.6.1 Clonidine
- •13.6.2 Brimonidine
- •13.6.3 Beta Receptors
- •13.6.4 Timolol
- •13.6.5 Human Studies
- •13.6.6 Betaxolol
- •13.6.7 Human Studies
- •13.6.8 Levobunolol
- •13.6.9 Carteolol
- •13.6.10 Serotonin
- •13.7 Carbonic Anhydrase Inhibitors
- •13.8 Acetazolamide
- •13.9 Dorzolamide
- •13.10 Retrobulbar Blood Flow
- •13.11 Retinal Blood Flow
- •13.12 Choroidal and Optic Nerve Head Blood Flow
- •13.13 Brinzolamide
- •References
- •Core Messages
- •14.1 Introduction
- •14.2 Retinal Ischemia Basic Mechanisms
- •14.3 Oxidative Stress
- •14.6 Animal Studies Relating Ischemia, Glaucoma, and Neuroprotection
- •14.6.1 Retinal Ischemia
- •14.6.6 Role of Mitochondria (Fig. 14.6)
- •References
- •Core Messages
- •15.1 Introduction
- •15.2 Retinal Blood Flow in Diabetes
- •15.3 Retinal Hypoperfusion
- •15.3.1 Mechanisms of Hypoperfusion
- •15.3.1.1 Glycaemic Control
- •15.3.1.2 Protein Kinase C
- •15.3.1.3 Ion Channel Dysfunction
- •15.4 Retinal Hyperperfusion
- •15.4.1 Mechanisms of Hyperperfusion: A Link to Hypoperfusion, Tissue Hypoxia and Retinal Leukostasis?
- •15.4.2 Retinal Autoregulation in Diabetes
- •15.5.1 Basement Membrane Thickening
- •15.5.3 Microaneurysms
- •15.5.4 Capillary Acellularity
- •15.6 Retinal Blood Flow and Vision Loss in Diabetic Retinopathy
- •15.6.1 Diabetic Macular Oedema
- •15.6.2 Proliferative Diabetic Retinopathy
- •15.7 Conclusions
- •15.8 Summary for the Clinician
- •References
- •Core Messages
- •16.1 Introduction
- •16.2 Choroidal Blood Flow
- •16.3 Systemic Vascular Factors and AMD
- •16.5 Choroidal Hemodynamic Changes in AMD
- •16.5.1 Choroidal Histopathological Vascular Changes in AMD
- •16.5.1.1 Choriocapillaris and Bruch’s Membrane in Aging and AMD
- •16.5.2 Choroidal Microcirculation in AMD
- •16.5.2.2 Choroidal Watershed Zones and Neovascularization
- •16.5.2.3 Laser Doppler Flowmetry Evaluation
- •References
- •Core Messages
- •17.1 Introduction
- •17.2 Potential Mechanisms of Ischaemic Damage in Glaucoma
- •17.2.2 Autoregulatory Disturbances
- •17.2.3 Mechanical Compression or Collapse of Vessels
- •17.2.4 Atherosclerosis
- •17.2.5 Vascular Endothelial Factors
- •17.2.6 Barriers to Nutrient Delivery
- •17.2.7 Circulating Vasoconstrictors
- •17.3 Evidence Base Supporting the Importance of Ischaemia in Glaucoma
- •17.3.1 Association and Causality
- •17.3.1.1 Reduction in Optic Nerve Head Blood Flow
- •17.3.1.2 Blood Pressure, Intraocular Pressure and Perfusion Pressure
- •17.3.1.3 Nocturnal Hypotension
- •17.3.1.4 Vasospasm
- •17.3.1.5 Endothelin and Other Circulating Peptides
- •17.3.2 Effects of Treatment
- •17.3.2.1 Calcium Channel Blockers
- •17.3.2.2 Topical Adrenergic Antagonists
- •17.3.2.4 Prostaglandin Analogues
- •17.4 Experimental Models of Ischaemia Relating to Glaucoma
- •17.4.1 Acute Ischaemia
- •17.4.2 Chronic Ischaemia
- •17.5 Summary
- •17.5.1 Diversity of Evidence
- •17.5.2 Evidence Base Compared to Intraocular Pressure
- •17.5.3 Requirements to Strengthen Evidence Base
- •References
- •Core Messages
- •18.1 Retinal Diseases
- •18.2 Uveitis
- •18.3 Optic Nerve Disorders
- •18.4 Systemic Diseases
- •References
- •Core Messages
- •19.1 Atherosclerosis
- •19.1.1 Pathogenesis of Atherosclerosis
- •19.1.2 Internal Carotid Artery Disease (ICA)
- •19.1.3 Effects on the Ocular Circulation
- •19.1.3.1 Retinal Artery Occlusion
- •Clinical Characteristics
- •Diagnosis
- •Mortality/Morbidity
- •19.1.3.2 Retinal Vein Occlusion (RVO)
- •Clinical Characteristics
- •Pathogenesis
- •Diagnosis
- •19.1.3.3 Ischemic Optic Neuropathy
- •Clinical Characteristics
- •Mortality/Morbidity
- •19.1.3.4 Asymptomatic Retinal Emboli
- •Background
- •Pathophysiology
- •19.2 Vasculitis
- •19.2.1 Takayasu’s Arteritis (Aortic Arch Syndrome)
- •19.2.1.1 Pathophysiology
- •19.2.1.2 Clinical Characteristics
- •19.2.1.3 Epidemiology
- •19.2.2 Behcet’s Disease
- •19.2.2.1 Clinical Characteristics
- •19.2.2.2 Pathogenesis
- •19.2.2.3 Diagnosis
- •19.2.2.4 Epidemiology
- •19.2.3 Thromboangiitis Obliterans
- •19.2.3.1 Diagnosis and Clinical Characteristics
- •19.2.3.2 Treatment
- •19.2.4 Temporal Arteritis
- •19.2.4.1 Epidemiology
- •19.2.4.2 Pathogenesis
- •19.2.4.3 Ocular Manifestations
- •19.2.5 Wegener’s Granulomatosis
- •19.2.5.1 Pathogenesis
- •19.2.5.2 Ocular Manifestation
- •19.2.5.3 Diagnosis
- •19.2.6 Kawasaki Disease
- •19.2.6.1 Clinical Characteristics
- •19.2.6.2 Diagnosis
- •19.3 Vascular Malformations
- •19.3.1.1 Diagnosis
- •19.3.1.2 Pathophysiology
- •19.4 Systemic Hypertension and Treatment
- •19.4.1 Etiology
- •19.4.1.1 Primary Hypertension
- •19.4.1.2 Secondary Hypertension
- •19.4.2 Pathophysiology
- •19.4.3 Pathology and Complications
- •19.4.4 Symptoms and Signs
- •19.4.5 Diagnosis of Hypertension
- •19.4.5.1 History
- •19.4.5.2 Physical Examination
- •19.4.5.3 Testing
- •19.4.6 Prognosis
- •19.4.7 General Treatment
- •19.4.7.2 Drugs
- •19.5 Hypertensive Retinopathy
- •19.5.2 Pathophysiology
- •19.5.3 Blood Pressure
- •19.5.3.1 The Risk of Stroke
- •19.5.3.2 The Risk of Coronary Heart Disease
- •19.5.4 Treatment
- •19.5.4.1 ACE Inhibitors and the Eye
- •References
- •Index
268 |
A. Reiner et al. |
|
|
Fig. 12.13 Figure 1 redrawn from Steinle et al. [322] showing a laser Doppler blood ßow record from the anterior choroid, posterior choroid, and vortex veins of rats during stimulation of either the SSN or the cervical sympathetic trunk (CST). The bar indicates the duration of the SSN (20 Hz) or the CST (12-Hz stimulation). Note that the CST stimulation decreased ChBF in posterior choroid, while SSN stimulation increased ßow in the anterior choroid and vortex veins
Flux (arbitrary units)
150
100
50
0
anterior choroid, SSN vortex veins, SSN posterior choroid, SSN posterior choroid, CST
20 |
40 |
60 |
80 |
100 |
|
|
Time (sec) |
|
|
also appear to be cholinergic [63, 354] and muscarinic agonists yield choroidal vasodilation [114, 218].
12.5.3.4 Choroidal Autoregulation and the PPG Input to Choroid – Mammals
The issue of choroidal autoregulation (i.e., compensation for ocular perfusion pressure changes so as to maintain ChBF near basal levels) has been somewhat controversial, since earlier studies reported that ChBF decreased linearly with reductions in choroidal perfusion pressure caused by acute hemorrhage or increased IOP [4, 10, 33, 37]. These observations had, in fact, led to a dogma that while cerebral blood ßow and retinal blood ßow do autoregulate to maintain stale ßow despite reduced ocular perfusion pressure, choroidal blood ßow does not. It became increasingly evident from subsequent studies, however, that ChBF does compensate for perfusion pressure declines. For example, some autoregulation with IOP elevations was noted in cats [97, 390], rabbits [54], and humans [292]. Detailed studies in rabbits have shown that when ocular perfusion pressure is experimentally reduced by lowering BP rather than by raising IOP, stable ChBF over a blood pressure (BP) range of 40Ð50 below basal BP is observed [169]. The compensation was hypothesized to stem from myogenic mechanisms [171]. In a later study, Kiel [173] noted that both NOS inhi-
bition and ganglionic blockade diminished the ChBF compensation to systemic hypotension in rabbit, implying some involvement of neurogenic vasodilatory mechanisms in the compensation. We refer to the blood ßow compensation for reduced systemic BP as baroregulation. By contrast, Jacot et al. [156] showed in piglet that ChBF compensation to perfusion pressure changes caused by IOP manipulation do not involve NO release, and thus involve different mechanisms that are involved in choroidal baroregulation. It is now evident than it is unlikely that ChBF would not show compensation for reduced ocular perfusion pressure, given the potentially adverse consequences of either supranormal ChBF or subnormal ChBF on retinal health and function. Without autoregulation, high BP would yield an ocular perfusion pressure resulting in excessively high ChBF, causing ßuid accumulation in retina and deÞcient exchange of wastes and nutrients between retina and choroid [35, 170]. Similarly, without autoregulation, low BP would yield an ocular perfusion pressure resulting in low ChBF, causing retinal hypoxia and impaired retinal function [325, 399, 400].
Given the input of hypothalamic and solitary nucleus blood pressure-sensitive sites to the choroidal neurons of the SSN [65, 147, 154, 323], at least part of the choroidal compensation to BP declines may be mediated by the SSN-PPG
12 Neural Control of Ocular Blood Flow |
269 |
|
|
circuit. Consistent with this possibility, prior studies have suggested that at least part of the compensation of cerebral blood ßow for declines in BP may be mediated by the PPG [121, 245]. Moreover, systemic hypotension does not activate sympathetic input to the choroid, while it does cause peripheral vasoconstriction [34]. Thus, the eye (like the brain) is a privileged tissue during systemic hypotension. Nonetheless, Linder [203] found that facial nerve stimulation increased choroidal blood ßow in hypotensive rabbit, but facial nerve section did not reduce choroidal blood ßow in hypotensive or normotensive rabbit, suggesting little contribution of the facial nerve system to hypotensive or normotensive tone in anesthetized rabbit. These results argue against the notion that the SSN-PPG circuit to the choroid participates in ChBF compensation for low systemic blood pressure, at least in rabbits. Given the anatomical evidence for BP-sensitive inputs to the SSN, however, further studies are needed to assess the contribution of the SSN-PPG circuit in mammals to ChBF baroregulation.
Note that the choroidal circulation does not appear to regulate (decrease) to high oxygen levels but does regulate (increase) in response to high CO2. For example, ChBF is unaltered in response to breathing 100% oxygen in humans [112, 167, 291] but is increased by breathing carbogen (95% O2 Ð 5% CO2) [112]. Similarly, hypercarbia increases ChBF in newborn piglets, cats, sheep, and baboons [5, 238, 332, 395]. High CO2 is also known to increase cerebral blood ßow as well [395]. The mechanism of the increased blood ßow with hypercapnia is uncertain. Schmetterer et al. [305] reported that NO is involved in hypercapnia-mediated increases in blood ßow in the human ophthalmic artery, raising the possibility that the same is true for the choroid. Cyclooxygenase products do not appear to mediate the hypercapnic ChBF increase in newborn piglets [331]. Note that some newborn mammals such as piglets [333] but not sheep [243] show a ChBF decrease to breathing 100% O2 Ð the increase in piglets also does not appear to be mediated by cyclooxygenase products. Whether vasodilatory PPG input plays a role in hypercapnic ChBF increases is unknown.
12.5.3.5Peripheral Anatomy of Facial Circuitry for Control
of ChBF – Birds
The pigeon PPG consists of an interconnected series of three to four microganglia of about 50Ð200 neurons each and numerous lesser microganglia (Figs. 12.14 and 12.15) [63]. The main microganglia of the PPG network in pigeons lie along the superior aspect of the Harderian gland. Neurons of all of these microganglia are extremely rich in VIP and nNOS, and moderate in ChAT (and thus make acetylcholine), and the majority co-contain VIP and nNOS (Fig. 12.16). In pigeons and chickens, the PPG has been shown to innervate choroidal vessels, as well as orbital vessels supplying the choroid [63, 85]. Axons containing VIP and nNOS extend from the PPG network to perivascular Þber plexi on orbital blood vessels [63]. These orbital vessels, many of which enter the choroid posteriorly and nasally, are a conduit by which PPG postganglionic Þbers reach the choroid (Fig. 12.15). Within the choroid, VIP+ and nNOS+ Þbers are widely scattered but sparse, and most abundant in nasal choroid. These results suggest that PPG neurons in birds use VIP and NO, and also possibly acetylcholine, to exert vasodilatory control over blood ßow to and within the avian choroid. A few VIP+ and nNOS+ neurons were also observed in the choroid. In some avian groups, such as ducks, many more intrinsic choroidal neurons co-containing VIP and nNOS have been reported [26, 306, 307, 309], as described here in more detail in a later section.
12.5.3.6Central Anatomy of Facial Circuitry for Control
of ChBF – Birds
Several studies have suggested that the preganglionic neurons innervating the PPG in birds reside in the superior salivatory nucleus in a similar brainstem location as in mammals [108, 228, 310]. Schroedl et al. [310] recently carried out a detailed anatomical study on the localization of the avian SSN (Fig. 12.17). ChAT+ neurons in brainstem were retrogradely labeled via the radix autonomica of the facial nerve, which conveys preganglionic axons from the SSN to the PPG. The SSN neurons were located dorsolateral to somatic facial
270 |
A. Reiner et al. |
|
|
a
|
OPH |
sup |
PPG |
|
|
||
|
Ciliary |
|
Harderian |
|
ganglion |
Optic |
gland |
|
|
nerve |
|
|
Oculomotor |
inf |
|
|
|
|
|
|
nerve |
|
Left eye |
|
Radix |
|
|
|
|
|
|
|
autonomica |
|
|
b |
Supraorbital |
|
|
|
artery |
|
|
Choroidal Ophthalmotemporal arteries
artery
Harderian Optic gland nerve
External |
Infraorbital |
Left eye |
|
ophthalmic artery |
artery |
||
|
Fig. 12.14 Schematic illustrations of the major ocular nerves (a) and vessels (b) and their relationship to the Harderian gland in birds, both as viewed from the posterior aspect of the left eye. Schematic (a) shows the course and relative locations of several major orbital nerves, as well as the locations of the ciliary ganglion (CG) and a simpliÞed version of the PPG system of microganglia. A more detailed version of the PPG is shown in Fig. 12.15. Schematic (b) illustrates the origin of the ophthalmotemporal artery from the external ophthalmic artery (which is itself a branch of the internal carotid) and its orbital course
along the left eye. Note the course of the ophthalmotemporal artery along the temporal, posterior, and nasal poles of the eye, and note that it gives rise to choroidal arteries throughout its course. It also gives rise to additional muscular and glandular branches. The ophthalmotemporal artery is accompanied by a vein of the same name whose major branches are somewhat different from those of the artery. Superior is to the top and nasal to the right in both schematics. inf inferior branch of oculomotor nerve, OPH ophthalmic nerve, sup superior branch of oculomotor nerve
motoneurons, as they are in mammals. As in mammals, the SSN region receives input from the nucleus of the solitary tract [14], the parabrachial region [394], and the SSN [180]. As in mammals,
the parabrachial region receives input from the nucleus of the solitary tract, which receives baroreceptive input [28, 164]. Thus, as in mammals, the avian SSN-PPG circuit may be responsive to
12 Neural Control of Ocular Blood Flow |
|
|
271 |
||
|
|
||||
a |
PPG Branches to ophthalmic nerve |
||||
|
|
Radix |
|
|
OPH |
|
|
autonomica |
|
|
|
|
|
|
|
PPG |
|
|
|
Harderian |
|
|
|
|
|
gland |
|
|
|
|
|
|
|
|
Duct of |
|
|
|
|
|
harderian |
|
|
|
|
|
gland |
|
|
|
|
|
Nasal branch of |
|
|
|
|
|
ophthalmotemporal |
|
|
|
|
|
artery |
b |
|
|
|
|
|
|
|
|
|
|
Retina |
|
|
|
|
|
Choroid |
|
|
|
|
|
Sclera |
PPG fibers |
|
|
|
|
Nasal branch of |
|
|
|
|
ophthalmotemporal |
|
innervating |
|
|
|
|
|
|
|
|
|
artery |
|
blood vessels |
|
|
|
|
|
|
|
|
|
|
Duct of |
|
|
Harderian |
|
|
harderian |
|
|
Gland |
|
|
gland |
|
|
|
PPG |
PPG fibers |
|
|
PPG |
Radix |
innervating |
||
|
|
|
|||
|
|
autonomica |
|
|
blood vessel |
Fig. 12.15 Image (a) provides a schematic view of the left Harderian gland and associated PPG plexus, as seen from the nasal side (i.e., the side facing the orbit). The ophthalmic nerve (OPH) is shown as coursing superior to the gland and receiving Þbers from the PPG plexus. The nasal branch of the ophthalmotemporal artery is shown behind the gland. The two major PPG microganglia are located along the superior aspect of the Harderian gland and are indicated by
arrows. The more rostral of these two is typically referred to as Òthe PPGÓ in many previous published works. NADPH-diaphorase neurons within the various microganglia are shown as solid circles. Image (b) provides a superior view of the Harderian gland and the ophthalmotemporal artery between it and the eye. Nerve Þbers on the artery and its branches to the choroid are illustrated
baroreceptor information and thus regulate ChBF as a function of systemic blood pressure.
12.5.3.7Physiological Studies of Facial Parasympathetic Control
of ChBF – Bird
In unpublished studies, we used transcleral LDF to measure ChBF in pigeons while systematically electrically stimulating brainstem in the vicinity of the facial motor nucleus, focusing on the region
of small cholinergic neurons between the two motoneuron pools comprising the SSN in chickens that had been shown to project to the PPG [108, 310]. We found that the region of the SSN of birds was effective for eliciting ChBF increases (100% or more) without signiÞcant concomitant systemic BP increases. The NOS inhibitor 7-nitroindazole (7NI) greatly attenuated (about 50%) the ChBF increases that could be elicited from this region, consistent with an involvement
272 |
A. Reiner et al. |
|
|
Fig. 12.16 Photomicrographs of immunolabeling in the main ganglion making up the avian PPG network. Images (aÐc) show three adjacent sections of the main PPG, labeled for VIP (a), NADPHd (b), and ChAT (c). The ganglion is rich in VIP+ and NADPHd+ perikarya, but poorer in ChAT perikarya. The ChAT perikarya are embedded within the ChAT+ neuropil of this PPG microganglion. The axon bundle shown to the extreme left in each photomicrograph contains VIP+, NADPHd+, and ChAT+ axons. The Harderian gland (HG) is shown to the upper left in all three photomicrographs. Images (dÐg) show single Þelds of view of the main PPG microganglion
in frontal sections, double-labeled by immunoßuorescence for VIP and nNOS. As can be seen in image pair (d and e), and a higher-power view of part of the same Þeld (f and g), numerous individual perikarya in the gland are labeled for VIP and nNOS. The large arrows in (d and e) indicate three such double-labeled neurons, and these same neurons are indicated in (f and g) by large arrows. In addition, a number of other neurons labeled for both VIP and nNOS are indicated in (f and g) by small arrows. MagniÞcation the same in (aÐc). MagniÞcation the same in (d and e). MagniÞcation the same in (f and g)
a |
|
|
b |
|
|
|
|
Cb |
|
Cb |
|
|
MCC |
|
|
|
|
||
|
|
|
V4 |
|
L |
|
|
Vem |
|
|
|
|
||
V4 |
Vem |
NVIII |
NVIII |
|
Flm |
||||
|
|
|
||
|
|
|
nVI |
|
Flm |
|
|
|
|
nVI |
nVI |
|
OS |
|
|
|
|||
|
|
|
||
|
|
OS |
|
|
|
NVI |
|
|
|
R |
|
|
R |
|
|
|
|
Fig. 12.17 Schematic images from Fig. 9 of Schrodl et al. [310]. The schematics show a mapping of the right side of the brainstem in a rostral (a) to caudal (b) pair of transverse sections. Preganglionic parasympathetic neurons of the SSN, as identiÞed by retrograde tracing, are indicated by open triangles. Black dots represent motoneu-
rons of somatic facial motor nucleus nerve VII. Cb cerebellum, Flm fasciculus longitudinalis medialis, L lingula, MCC nucleus magnocellularis cochlearis, nVI nucleus abducens, NVI nervus abducens, NVIII nervus vestibulocochlearis, OS nucleus olivaris, V4 fourth ventricle, Vem nucleus vestibularis medialis, R raphe nucleus
